Related Experiment Video

Updated: Aug 19, 2026

Isolation, Transfection, and Culture of Primary Human Monocytes
09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

Risk factors for myocardial infarction in HIV-positive patients

E Quiros-Roldan1, C Torti, C Tinelli

  • 1Department of Infectious and Tropical Diseases, Pzle Spedali Civili 1, Brescia 25123, Italy. kaeniaquiros@hotmail.com

International Journal of STD & AIDS
|February 12, 2005
PubMed

Insights

In HIV-infected patients, protease inhibitor (PI) use was not linked to myocardial infarction (MI). Advanced HIV infection, indicated by low CD4 counts and high viral load, may be associated with MI risk.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • HIV/AIDS Research

Background:

  • Cardiovascular disease is a significant concern in HIV-infected individuals.
  • Understanding risk factors for myocardial infarction (MI) in this population is crucial.

Purpose of the Study:

  • To investigate the clinical characteristics of myocardial infarction (MI) in HIV-infected patients.
  • To compare MI patients with a matched control group to identify associated risk factors.
  • To assess the impact of protease inhibitor (PI) use on MI risk in HIV patients.

Main Methods:

  • Retrospective analysis of 12 HIV-infected patients with MI.
  • Conditional (fixed-effect) logistic regression for matched case-control analysis (1:2).
  • Comparison of cardiovascular risk factors, including PI use, CD4+ T-cell count, and HIV RNA levels.

Main Results:

  • 6 out of 12 MI patients had no prior protease inhibitor (PI) use or were antiretroviral therapy naive.
  • Low nadir CD4+ T-cell count (<50/mm³) and high peak HIV RNA levels (>100,000 copies/mL) were marginally associated with MI.
  • Protease inhibitor (PI) use was not significantly associated with an increased risk of MI.

Conclusions:

  • Protease inhibitor (PI) use does not appear to increase myocardial infarction (MI) risk in HIV-infected patients.
  • Advanced HIV infection, characterized by low CD4 counts and high viral loads, warrants further investigation as a potential MI risk factor.
  • Further research is needed to elucidate the complex relationship between HIV infection and cardiovascular events.

More Related Videos

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...